155 related articles for article (PubMed ID: 27648827)
1. Association between P16INK4a Promoter Methylation and Ovarian Cancer: A Meta-Analysis of 12 Published Studies.
Xiao X; Cai F; Niu X; Shi H; Zhong Y
PLoS One; 2016; 11(9):e0163257. PubMed ID: 27648827
[TBL] [Abstract][Full Text] [Related]
2. Association between P16INK4a promoter methylation and HNSCC: a meta-analysis of 21 published studies.
Shi H; Chen X; Lu C; Gu C; Jiang H; Meng R; Niu X; Huang Y; Lu M
PLoS One; 2015; 10(4):e0122302. PubMed ID: 25835498
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis demonstrates no association between p16
Jiang Y; Yan F; Liang L; Wan Y; Liu J; Cheng W
Arch Gynecol Obstet; 2017 Mar; 295(3):697-704. PubMed ID: 28000027
[TBL] [Abstract][Full Text] [Related]
4. Association between RASSF1A promoter methylation and ovarian cancer: a meta-analysis.
Shi H; Li Y; Wang X; Lu C; Yang L; Gu C; Xiong J; Huang Y; Wang S; Lu M
PLoS One; 2013; 8(10):e76787. PubMed ID: 24116157
[TBL] [Abstract][Full Text] [Related]
5. [Disfigurement of p16INK4A gene expression in development of ovarian cancer and the mechanism].
Li M; Huang ZJ; Dong WH; Li XY; Wang XY; He XH; Wang H; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):408-12. PubMed ID: 16831366
[TBL] [Abstract][Full Text] [Related]
6. Methylation and messenger RNA expression of p15INK4b but not p16INK4a are independent risk factors for ovarian cancer.
Liu Z; Wang LE; Wang L; Lu KH; Mills GB; Bondy ML; Wei Q
Clin Cancer Res; 2005 Jul; 11(13):4968-76. PubMed ID: 16000597
[TBL] [Abstract][Full Text] [Related]
7. Bronchial lavage P 16INK4A gene promoter methylation and lung cancer diagnosis: A meta-analysis.
Yifan D; Qun L; Yingshuang H; Xulin L; Jianjun W; Qian M; Yuman Y; Zhaoyang R
Indian J Cancer; 2015 Dec; 52 Suppl 2():e96-8. PubMed ID: 26728683
[TBL] [Abstract][Full Text] [Related]
8. Promoter methylations of p16INK4a and p14ARF genes in early and advanced gastric cancer. Correlations of the modes of their occurrence with histologic type.
Tsujimoto H; Hagiwara A; Sugihara H; Hattori T; Yamagishi H
Pathol Res Pract; 2002; 198(12):785-94. PubMed ID: 12608655
[TBL] [Abstract][Full Text] [Related]
9. Downregulation and aberrant promoter methylation of p16INK4A: a possible novel heritable susceptibility marker to retinoblastoma.
Indovina P; Acquaviva A; De Falco G; Rizzo V; Onnis A; Luzzi A; Giorgi F; Hadjistilianou T; Toti P; Tomei V; Pentimalli F; Carugi A; Giordano A
J Cell Physiol; 2010 Apr; 223(1):143-50. PubMed ID: 20039270
[TBL] [Abstract][Full Text] [Related]
10. Lack of mutation at p16INK4A gene but expression of aberrant p16INK4A RNA transcripts in human ovarian carcinoma.
Suh SI; Cho JW; Baek WK; Suh MH; Carson DA
Cancer Lett; 2000 May; 153(1-2):175-82. PubMed ID: 10779647
[TBL] [Abstract][Full Text] [Related]
11. Relationships between p16 gene promoter methylation and clinicopathologic features of colorectal cancer: a meta-analysis of 27 cohort studies.
Chen YZ; Liu D; Zhao YX; Wang HT; Gao Y; Chen Y
DNA Cell Biol; 2014 Oct; 33(10):729-38. PubMed ID: 24979649
[TBL] [Abstract][Full Text] [Related]
12. Methylation of p16INK4A in primary gynecologic malignancy.
Wong YF; Chung TK; Cheung TH; Nobori T; Yu AL; Yu J; Batova A; Lai KW; Chang AM
Cancer Lett; 1999 Mar; 136(2):231-5. PubMed ID: 10355753
[TBL] [Abstract][Full Text] [Related]
13. Clinical and prognostic effects of
Xia L; Zhang W; Gao L
Biomarkers; 2019 Nov; 24(7):700-711. PubMed ID: 31382782
[No Abstract] [Full Text] [Related]
14. The association between CDH1 promoter methylation and patients with ovarian cancer: a systematic meta-analysis.
Wang Q; Wang B; Zhang YM; Wang W
J Ovarian Res; 2016 Apr; 9():23. PubMed ID: 27067410
[TBL] [Abstract][Full Text] [Related]
15. CDKN2A promoter methylation and hepatocellular carcinoma risk: A meta-analysis.
Zhou Y; Wang XB; Qiu XP; Shuai Zhang ; Wang C; Zheng F
Clin Res Hepatol Gastroenterol; 2018 Dec; 42(6):529-541. PubMed ID: 30143452
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic alteration of p16INK4a gene in dedifferentiation of liposarcoma.
He M; Aisner S; Benevenia J; Patterson F; Harrison LE; Hameed M
Pathol Res Pract; 2009; 205(6):386-94. PubMed ID: 19186005
[TBL] [Abstract][Full Text] [Related]
17. P16
Tuo L; Sha S; Huayu Z; Du K
Thorac Cancer; 2018 Aug; 9(8):1032-1040. PubMed ID: 29927090
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis.
Hsieh CJ; Klump B; Holzmann K; Borchard F; Gregor M; Porschen R
Cancer Res; 1998 Sep; 58(17):3942-5. PubMed ID: 9731506
[TBL] [Abstract][Full Text] [Related]
19. p16 gene alterations in human ovarian cancers: comparison between tissue and blood samples.
Bammidi LS; Neerukonda GN; Murthy S; Kanapuram RD
Int J Gynecol Cancer; 2012 May; 22(4):553-60. PubMed ID: 22344043
[TBL] [Abstract][Full Text] [Related]
20. Aberrant promoter hypermethylation of p16 gene in endometrial carcinoma.
Hu ZY; Tang LD; Zhou Q; Xiao L; Cao Y
Tumour Biol; 2015 Mar; 36(3):1487-91. PubMed ID: 25596080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
